Weekly Adaptive Radiotherapy vs Standard Intensity-Modulated Radiotherapy for Improving Salivary Function in Patients With Head and Neck Cancer. A Phase 3 Randomized Clinical Trial

Castelli J, Thariat J, Benezery K, Hasbini A, Gery B, Berger A, Liem X, Guihard S, Chapet S, Thureau S, Auberdiac P, Pommier P, Ruffier A, Perrier L, Devillers A, Campillo-Gimenez B, de Crevoisier R.

Journal: JAMA Oncol.

Année: Jun 2023

Volume: e231352

Hypofractionated radiotherapy for invasive squamous cell carcinoma of the scalp in the elderly: Efficacy and tolerance, preliminary results

Jacques J, Renard S, Demogeot N, Faivre JC, Peiffert D.

Journal: Cancer Radiother.

Année: Jun 2023

Volume: 27(4):290-295

Zoledronate and osteonecrosis of the jaw in osteoporosis: incidence and risk factors. Analysis of the French Pharmacovigilance Database

Amigues C , Fresse A , Roux CH , Gauthier S , Vieillard MH , Drici MD , Breuil V; French Network of Pharmacovigilance Centers.

Journal: Joint Bone Spine .

Anneé: June 2023;

Volume: 105599.

Online ahead of print.

Clinical Applications and Controversies of Whole-Body MRI: AJR Expert Panel Narrative Review

Ahlawat S, Debs P, Amini B, Lecouvet FE, Omoumi P, Wessell DE. AJR Am J Roentgenol

Journal: AJR

Année: Apr 2023

Volume: 220(4):463-475

Engineering of a Bispecific Nanofitin with Immune Checkpoint Inhibitory Activity Conditioned by the Cross-Arm Binding to EGFR and PDL1

Jacquot P, Muñoz-Garcia J, Fleury M, Cochonneau D, Gaussin R, Enouf E, Roze C, Ollivier E, Cinier M, Heymann D.

Journal: Biomolecules.

Année: Mar 2023

Vomume: 13(4):636

Quantitative MRI to Characterize Hypoxic Tumors in Comparison to FMISO PET/CT for Radiotherapy in Oropharynx Cancers

Gouel P, Callonnec F, Obongo-Anga FR, Bohn P, Lévêque E, Gensanne D, Hapdey S, Modzelewski R, Vera P, Thureau S.

Journal: Cancers (Basel).

Année: Mar 2023 Mar


Could conventionally fractionated radiation therapy coupled with stereotactic body radiation therapy improve local control in bone oligometastases?

Py JF, Salleron J, Vogin G, Courrech F, Teixeira P, Colnat-Coulbois S, Baumard F, Thureau S, Supiot S, Peiffert D, Oldrini G, Faivre JC.

Journal: Cancer/ Radiothérapie
Volume: 27, Issue 1
Année: Février 2023
Pages: 1-10

Specific targeting of inflammatory osteoclastogenesis by the probiotic yeast S. boulardii CNCM I-745 reduces bone loss in osteoporosis.

Madel MB, Halper J, Ibáñez L, Claire L, Rouleau M, Boutin A, Mahler A, Pontier-Bres R, Ciucci T, Topi M, Hue C, Amiaud J, Iborra S, Sancho D, Heymann D, Garchon HJ, Czerucka D, Apparailly F, Duroux-Richard I, Wakkach A, Blin-Wakkach C.

Journal: eLife
Année: Février 2023

Preserving bone in cancers of the elderly: a necessity

Bertrand N, Bridoux M, Gaxatte C, Rached HA, Turpin A, Letarouilly JG, Vieillard MH.

Journal: Joint Bone Spine
Volume: 90, Issue 4
Année: Juillet 2023
Pages: 105549